Heme oxygenase-1 induction restores high-blood-flow-dependent remodeling and endothelial function in mesenteric arteries of old rats

Journal of Hypertension

Volumn 29, Issue 1, 2011, Pages 102-112

  Freidja, Mohamed Lamine ^a,b,d   Vessieres, Emilie ^a,b,d   Clere, Nicolas ^d   Desquiret, Valerie ^a,b,d   Guihot, Anne Laure ^a,b,d   Toutain, Bertrand ^a,b,d   Loufrani, Laurent ^a,b,d   Jardel, Alain ^a,b,d   Procaccio, Vincent ^a,b,d   Faure, Sebastien ^d   Henrion, Daniel ^a,b,c,d  

^a CNRS   (France)

^b INSERM   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ D'ANGERS   (France)

Author keywords

aging; blood flow; heme oxygenase 1; ischemic disease; oxidative stress; remodeling; resistance arteries; shear stress

Indexed keywords

ACONITATE HYDRATASE; HEME OXYGENASE 1; MANGANESE SUPEROXIDE DISMUTASE; PROTOPORPHYRIN COBALT; REACTIVE OXYGEN METABOLITE;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY LIGATION; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INDUCTION; MESENTERIC ARTERY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 78650816359     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833db36e     Document Type: Article

References (49)

1. Koller A, Huang A, Sun D, Kaley G. Exercise training augments flow-dependent dilation in rat skeletal muscle arterioles. Role of endothelial nitric oxide and prostaglandins. Circ Res 1995; 76:544-550.
2. Dumont O, Loufrani L, Henrion D. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler Thromb Vasc Biol 2007; 27:317-324.
3. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 2005; 46:454-462.
4. Tuttle JL, Hahn TL, Sanders BM, Witzmann FA, Miller SJ, Dalsing MC, Unthank JL. Impaired collateral development in mature rats. Am J Physiol Heart Circ Physiol 2002; 283:H146-155.
5. Dumont O, Pinaud F, Guihot AL, Baufreton C, Loufrani L, Henrion D. Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine. Cardiovasc Res 2008; 77:600-608.
6. Sun D, Huang A, Yan EH, Wu Z, Yan C, Kaminski PM, et al. Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am J Physiol Heart Circ Physiol 2004; 286:H2249-H2256.
7. Ryter SW, Choi AM. Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signal 2002; 4:625-632.
8. Hoekstra KA, Godin DV, Kurtu J, Cheng KM. Effects of oxidant-induced injury on heme oxygenase and glutathione in cultured aortic endothelial cells from atherosclerosis-susceptible and -resistant Japanese quail. Mol Cell Biochem 2003; 254:61-71. (Pubitemid 37483740)
9. Vogt BA, Alam J, Croatt AJ, Vercellotti GM, Nath KA. Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Lab Invest 1995; 72:474-483.
10. McCoubrey WK Jr, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 1997; 247:725-732.
11. Wagener FA, da Silva JL, Farley T, de Witte T, Kappas A, Abraham NG. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 1999; 291:416-423.
12. Kaide JI, ZhangF, Wei Y, Jiang H, Yu C, Wang WH, et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 2001; 107:1163-1171.
13. Arregui B, Lopez B, Garcia Salom M, Valero F, Navarro C, Fenoy FJ. Acute renal hemodynamic effects of dimanganese decacarbonyl and cobalt protoporphyrin. Kidney lnt 2004; 65:564-574.
14. Ryter SW, Otterbein LE. Carbon monoxide in biology and medicine. Bioessays 2004; 26:270-280.
15. Kushida T, Quan S, Yang L, Ikehara S, Kappas A, Abraham NG. A significant role for the heme oxygenase-1 gene in endothelial cell cycle progression. Biochem Biophys Res Commun 2002; 291:68-75.
16. Mazza F, Goodman A, Lombardo G, Vanella A, Abraham NG. Heme oxygenase-1 gene expression attenuates angiotensin II-mediated DNA damage in endothelial cells. Exp Biol Med (Maywood) 2003; 228:576-583.
17. Otterbein LE. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 2002; 4:309-319.
18. Nakao A, Kimizuka K, Stolz DB, Neto JS, Kaizu T, Choi AM, et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 2003; 163:1587-1598. (Pubitemid 37175105)
19. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286:H1649-H1653.
20. Vera T, Henegar JR, Drummond HA, Rimoldi JM, Stec DE. Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol 2005; 16:950-958.
21. Wagner CT, Durante W, Christodoulides N, Heliums JD, Schafer AI. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 1997; 100:589-596. (Pubitemid 27340506)
22. Braam B, de Roos R, Bluyssen H, Kemmeren P, Holstege F, Joles JA, Koomans H. Nitric oxide-dependent and nitric oxide-independent transcriptional responses to high shear stress in endothelial cells. Hypertension 2005; 45:672-680.
23. Unthank JL, Fath SW, Burkhart HM, Miller SC, Dalsing MC. Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. Circ Res 1996; 79:1015-1023.
24. Pourageaud F, De Mey JG. Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am J Physiol 1997; 273:H1699-1706.
25. Driss BA, Devaux C, Henrion D, Duriez M, Thuillez C, Levy BI, Michel JB. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 2000; 101:2764-2770.
26. Henrion D, Terzi F, Matrougui K, Duriez M, Boulanger CM, Colucci- Guyon E, et al. Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin. J Clin Invest 1997; 100:2909-2914.
27. Belin de Chantemele EJ, Vessieres E, Guihot AL, Toutain B, Maquignau M, Loufrani L, Henrion D. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Cardiovasc Res 2009; 81:788-796.
28. Dowell FJ, Henrion D, Duriez M, Michel JB. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br J Pharmacol 1996; 117:341-346.
29. Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 1997; 17:215-217.
30. Flamment M, Arvier M, Gallois Y, Simard G, Malthiery Y, Ritz P, Ducluzeau PH. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction. Biochimie 2008; 90:1407-1413.
31. Galbraith RA, Kappas A. Regulation of food intake and body weight by cobalt porphyrins in animals. Proc Natl Acad Sci USA 1989; 86:7653-7657.
32. Galbraith RA, Kappas A. Regulation of food intake and body weight in rats by the synthetic heme analogue cobalt protoporphyrin. Am J Physiol 1991; 261:R1388-1394.
33. Galbraith RA, Kappas A. Cobalt protoporphyrin regulates body weight in beagle dogs: induction of weight loss in normal animals of stable adult weight. Pharmacology 1991; 43:96-105.
34. Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004; 286:R431-R444.
35. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340:14-22.
36. Kim DH, Kim JH, Kim EH, Na HK, Cha YN, Chung JH, Surh YJ. 15- Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. Carcinogenesis 2009; 30:645-654.
37. Ahmad M, Turkseven S, Mingone CJ, Gupte SA, Wolin MS, Abraham NG. Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats. Cell Mol Biol (Noisy-le-grand) 2005; 51:371-376.
38. Porteri E, Rodella LF, Rezzani R, Rizzoni D, Paiardi S, de Ciuceis C, et al. Role of heme oxygenase in modulating endothelial function in mesenteric small resistance arteries of spontaneously hypertensive rats. Clin Exp Hypertens 2009; 31:560-571.
39. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92:1475-1479.
40. Samora JB, Goodwill AG, Frisbee JC, Boegehold MA. Growth-dependent changes in the contribution of carbon monoxide to arteriolar function. J Vasc Res 2009; 47:23-34.
41. Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury- induced vascular neointima formation. Circulation 2001; 104:2710-2715.
42. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 2000; 86:1224-1229.
43. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, et al. Small artery remodeling depends on tissue-type transglutaminase. Circ Res 2005; 96:119-126.
44. Koller A. Flow-dependent remodeling of small arteries: the stimuli and the sensors are (still) in question. Circ Res 2006; 99:6-9.
45. Khan ZA, Barbin YP, Cukiernik M, Adams PC, Chakrabarti S. Heme-oxygenase-mediated iron accumulation in the liver. Can J Physiol Pharmacol 2004; 82:448-456.
46. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60:79-127.
47. Saner H. [Cardiovascular system and aging]. Ther Umsch 2005; 62:827-835.
48. Li C, Hossieny P, Wu BJ, Qawasmeh A, Beck K, Stocker R. Pharmacologic induction of heme oxygenase-1. Antioxid Redox Signal 2007; 9:2227-2239.
49. Dreger H, Lorenz M, Kehrer A, Baumann G, Stangl K, Stangl V. Characteristics of catechin- and theaflavin-mediated cardioprotection. Exp Biol Med (Maywood) 2008; 233:427-433.